Supplier
Indiana University Health Bloomington INC
Indiana University Health Bloomington INC was paid $28.69M by Medicaid between Jan 2018 and Nov 2024, across 191 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 16% of everything it billed.
33Billing provider infoINDIANA UNIVERSITY HEALTH BLOOMINGTON INC
BLOOMINGTON, IN 47408
BLOOMINGTON, IN 47408
33aNPI1205860335assigned 07/11/2006
33bProvider typeDurable Medical Equipment & Medical Supplies
28Total paid$28.69M
24GClaims584,271
24DCodes billed191
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Durable Medical Equipment & Medical Supplies providers in Indiana
Rank by total paid#3 of 560
Median peer was paid$29.96
This provider vs. median957,527×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official CRAIG, MICHAEL controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 88,699 | $1.37M | |
| 2019 | 80,084 | $3.02M | |
| 2020 | 69,131 | $3.37M | |
| 2021 | 92,207 | $5.34M | |
| 2022 | 106,367 | $5.81M | |
| 2023 | 92,572 | $6.07M | |
| 2024incomplete | 55,211 | $3.72M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 16% | 42,287 | 36,343 | $4.70M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 28,535 | 26,236 | $3.68M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 29,607 | 25,758 | $3.48M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 27,009 | 24,254 | $3.43M |
| 71045 | Radiologic examination, chest; single view | 5.6% | 13,625 | 11,985 | $1.61M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 5.0% | 25,033 | 21,823 | $1.44M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.5% | 24,522 | 21,451 | $1.29M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2.7% | 1,459 | 694 | $775K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 2.1% | 6,371 | 4,103 | $601K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.0% | 514 | 484 | $566K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 1.6% | 6,360 | 4,757 | $449K |
| 59025 | Fetal non-stress test | 1.5% | 1,339 | 1,076 | $417K |
179 more codes
| 90853 | Group psychotherapy (other than of a multiple-family group) | 1.4% | 6,698 | $391K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.4% | 13,871 | $387K |
| A0427 | Emergency ambulance ride, advanced life support | 1.1% | 5,082 | $312K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1.1% | 4,234 | $306K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,061 | $285K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 57,750 | $231K |
| 90899 | <1% | 705 | $224K | |
| 80053 | Comprehensive metabolic panel | <1% | 38,303 | $223K |
| A0425 | Ground mileage, per statute mile | <1% | 16,510 | $212K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,485 | $210K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 4,153 | $205K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 114 | $203K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,762 | $153K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,727 | $129K |
| 36415 | Collection of venous blood by venipuncture | <1% | 37,571 | $127K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 3,339 | $125K |
| 80320 | <1% | 1,304 | $123K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,671 | $118K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 3,673 | $117K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,640 | $115K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,003 | $111K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,781 | $105K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,576 | $94K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 820 | $88K |
| 80050 | General health panel | <1% | 650 | $83K |
| 93296 | <1% | 463 | $76K | |
| 77386 | <1% | 342 | $69K | |
| 84484 | <1% | 12,717 | $68K | |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 3,138 | $63K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 224 | $61K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,906 | $54K |
| 80061 | Lipid panel | <1% | 6,130 | $54K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 13,288 | $51K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,786 | $51K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 8,055 | $49K |
| 77336 | <1% | 382 | $44K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 9,888 | $44K |
| 81003 | <1% | 25,265 | $42K | |
| H0038 | Self-help/peer services, per 15 minutes | <1% | 583 | $39K |
| 99221 | <1% | 89 | $39K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 585 | $35K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 360 | $35K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 291 | $34K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,915 | $32K |
| 81025 | <1% | 5,674 | $27K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,546 | $25K |
| 83690 | <1% | 8,717 | $24K | |
| 87503 | <1% | 1,354 | $22K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 187 | $21K |
| 87660 | <1% | 1,251 | $20K | |
| 87510 | <1% | 1,251 | $20K | |
| 87480 | <1% | 1,251 | $20K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 15 | $20K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 193 | $19K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,059 | $17K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 101 | $17K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 494 | $16K |
| 81001 | <1% | 11,834 | $16K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 435 | $15K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 460 | $14K |
| 87536 | <1% | 236 | $14K | |
| 80348 | <1% | 166 | $14K | |
| 83605 | <1% | 2,718 | $14K | |
| 80047 | <1% | 3,491 | $12K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 368 | $11K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,024 | $11K |
| 80349 | <1% | 215 | $10K | |
| 82607 | <1% | 950 | $10K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 128 | $9K |
| 85027 | <1% | 2,180 | $9K | |
| 83735 | <1% | 2,586 | $8K | |
| 80365 | <1% | 50 | $8K | |
| 80359 | <1% | 96 | $7K | |
| 86360 | <1% | 208 | $7K | |
| 80325 | <1% | 96 | $7K | |
| 86780 | <1% | 611 | $7K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 44 | $7K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 615 | $6K |
| 95886 | <1% | 16 | $6K | |
| 86359 | <1% | 232 | $6K | |
| 80076 | <1% | 1,420 | $6K | |
| 97597 | <1% | 79 | $5K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 30 | $5K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 32 | $5K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 38 | $5K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 13 | $4K |
| 85610 | <1% | 2,233 | $4K | |
| 87522 | Neg quan hep c or qual rna | <1% | 118 | $4K |
| 85014 | <1% | 5,215 | $4K | |
| 84439 | <1% | 558 | $4K | |
| 64483 | <1% | 14 | $4K | |
| 80361 | <1% | 50 | $4K | |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | <1% | 513 | $4K |
| 88142 | <1% | 266 | $4K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 158 | $3K |
| 83516 | <1% | 468 | $3K | |
| 82670 | <1% | 146 | $3K | |
| 77334 | <1% | 24 | $3K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 29 | $3K |
| 86140 | <1% | 887 | $3K | |
| 83880 | <1% | 191 | $2K | |
| 85379 | <1% | 453 | $2K | |
| 83655 | <1% | 218 | $2K | |
| 84403 | <1% | 115 | $2K | |
| 80329 | <1% | 111 | $2K | |
| 77300 | <1% | 36 | $2K | |
| 86803 | <1% | 155 | $2K | |
| 87653 | <1% | 87 | $2K | |
| 84144 | <1% | 112 | $2K | |
| 84402 | <1% | 88 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 47 | $2K |
| 84270 | <1% | 87 | $2K | |
| 82746 | <1% | 155 | $2K | |
| 85730 | <1% | 572 | $1K | |
| 82570 | <1% | 525 | $1K | |
| 84481 | <1% | 90 | $1K | |
| 82043 | <1% | 378 | $1K | |
| 83970 | <1% | 77 | $1K | |
| 94760 | <1% | 31 | $1K | |
| 86850 | <1% | 244 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 75 | $1K |
| 82803 | <1% | 105 | $1K | |
| 82553 | <1% | 307 | $850.27 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 26 | $846.25 |
| 83001 | <1% | 61 | $838.53 | |
| 82550 | <1% | 322 | $805.83 | |
| 83002 | <1% | 44 | $704.55 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 34 | $687.74 |
| 82627 | <1% | 34 | $645.62 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 15 | $636.48 |
| 87340 | <1% | 83 | $634.61 | |
| 82728 | <1% | 87 | $608.11 | |
| 87040 | <1% | 132 | $570.15 | |
| 86900 | <1% | 228 | $526.61 | |
| 86901 | <1% | 228 | $526.61 | |
| 82948 | <1% | 288 | $502.44 | |
| 84702 | <1% | 59 | $454.73 | |
| 86762 | <1% | 29 | $402.92 | |
| 82951 | <1% | 27 | $370.65 | |
| 85652 | <1% | 239 | $357.59 | |
| 83540 | <1% | 84 | $341.62 | |
| 86317 | <1% | 28 | $323.34 | |
| 83550 | <1% | 54 | $309.74 | |
| 82330 | <1% | 360 | $309.63 | |
| 82150 | <1% | 97 | $306.45 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 36 | $294.84 |
| 84156 | <1% | 143 | $287.83 | |
| 87150 | <1% | 12 | $284.23 | |
| 84425 | <1% | 14 | $281.08 | |
| 82565 | <1% | 392 | $236.62 | |
| 84295 | <1% | 393 | $217.45 | |
| 84132 | <1% | 433 | $215.39 | |
| 82947 | <1% | 407 | $208.15 | |
| 82435 | <1% | 393 | $186.64 | |
| 80069 | <1% | 46 | $185.38 | |
| 84520 | <1% | 396 | $178.43 | |
| 83615 | <1% | 172 | $163.95 | |
| 80143 | <1% | 12 | $160.37 | |
| 87077 | <1% | 56 | $150.79 | |
| 84480 | <1% | 13 | $133.58 | |
| 82374 | <1% | 339 | $119.40 | |
| 87186 | <1% | 30 | $96.05 | |
| 84100 | <1% | 40 | $86.74 | |
| 82977 | <1% | 13 | $64.50 | |
| 84450 | <1% | 26 | $63.79 | |
| 82950 | <1% | 12 | $55.11 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 25 | $51.60 |
| 87070 | <1% | 38 | $26.00 | |
| 87205 | <1% | 38 | $12.89 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 969 | $0.00 |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 0% | 40 | $0.00 |
| 81291 | 0% | 17 | $0.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 20 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 446 | $0.00 |
| 96376 | 0% | 152 | $0.00 | |
| 99459 | 0% | 494 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 115 | $0.00 |
| G0378 | Hospital observation service, per hour | 0% | 13 | $0.00 |
| 0064U | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCRAIG, MICHAEL (CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Indiana University Health Southern Indiana Physicians, LLC | Bloomington, IN | $69.64M |
| Indiana University Health Arnett INC | Lafayette, IN | $26.01M |
| Southern Indiana Pediatrics, LLC | Bloomington, IN | $10.70M |
| Indiana University Health Bedford, INC | Bedford, IN | $8.45M |
| Indiana University Health Paoli INC | Paoli, IN | $4.44M |
| Indiana University Health Bloomington INC | Bloomington, IN | $1.49M |
| Indiana University Health Paoli INC | Paoli, IN | $1.10M |
| Iu Health Bedford Physicians, LLC | Bedford, IN | $1000K |
| Iu Health Morgan Physicians, LLC | Martinsville, IN | $534K |
| Wagoner Family Dentistry, PC | Wagoner, OK | $510K |
| Orthopedics of South Central Indiana LLC | Bloomington, IN | $239K |
| Ambulance Service of Murfreesboro, LLC | Murfreesboro, TN | $16K |
| Bloomington Endoscopy Center, LLC | Bloomington, IN | $0.00 |
| Indiana University Health Southern Indiana Physicians, LLC | Bloomington, IN | $0.00 |
| Indiana University Health Southern Indiana Physicians LLC | Bloomington, IN | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.